Accounts Payable - Abbvie Inc (NYSE:ABBV) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 159.62 USD -4.58%

Updated:

Abbvie Inc
Accounts Payable

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Abbvie Inc
Accounts Payable Peer Comparison

GILD

AMGN

MRNA

VRTX

REGN

Company		Accounts Payable	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Abbvie Inc NYSE:ABBV	Accounts Payable $30.7B	CAGR 3-Years 15%	CAGR 5-Years 21%	CAGR 10-Years 17%
	Gilead Sciences Inc NASDAQ:GILD	Accounts Payable $550m	CAGR 3-Years -13%	CAGR 5-Years -7%	CAGR 10-Years -8%
	Amgen Inc NASDAQ:AMGN	Accounts Payable $18.5B	CAGR 3-Years 135%	CAGR 5-Years 73%	CAGR 10-Years 37%
	Moderna Inc NASDAQ:MRNA	Accounts Payable $520m	CAGR 3-Years 207%	CAGR 5-Years 76%	CAGR 10-Years N/A
	Vertex Pharmaceuticals Inc NASDAQ:VRTX	Accounts Payable $3.4B	CAGR 3-Years 180%	CAGR 5-Years 98%	CAGR 10-Years 53%
	Regeneron Pharmaceuticals Inc NASDAQ:REGN	Accounts Payable $4.4B	CAGR 3-Years 110%	CAGR 5-Years 83%	CAGR 10-Years 53%

See Also

Based on the financial report for Dec 31, 2023, Abbvie Inc's Accounts Payable amounts to 30.7B USD.

Over the last year, the Accounts Payable growth was 21%. The average annual Accounts Payable growth rates for Abbvie Inc have been 15% over the past three years , 21% over the past five years , and 17% over the past ten years .

Join more than 131,700+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.